CONMED (CNMD) reported Q2 adjusted earnings late Wednesday of $1.38 per diluted share, up from $1.15 a year earlier.

Analysts polled by FactSet expected $1.11.

Revenue in the three months ended June 30 rose to $343.5 million from $342.3 million a year earlier.

Analysts surveyed by FactSet expected $337.6 million.

The company raised its full-year adjusted EPS guidance to $4.48 to $4.60 from its prior outlook of $4.30 to $4.45 and updated its revenue guidance to $1.358 billion to $1.373 billion from $1.350 billion to $1.375 billion.

Analysts expect EPS of $4.52 on revenue of $1.36 billion.

Shares of the company were up 6.5% in premarket activity.